|
Status |
Public on Feb 10, 2021 |
Title |
p53 influences 5-FU-induced chromatin accessibility [ChIP-seq] |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
5-Fluorouracil (5-FU) is one of the most common drugs used in chemotherapy because of its efficacy and stability. However, 5-FU has been known to work on only 10~15% of colon cancer patients. Therefore, the study of 5-FU sensitivity study is necessary to increase the survival of colon cancer patients. p53 is one of the factors that effect on drug sensitivity. Main function of p53 has been focused on transcription activity in cell death. Numerous drug related studies show that expression of wild-type p53 increases drug sensitivity in various cancer types through inducing apoptotic signaling pathways. Currently, it has been reported that p53 has both transcriptional and non-transcriptional activities in apoptosis. However, most studies about p53 non-transcriptional activities in apoptosis are mainly focused on p53 induced mitochondrial outer membrane permeabilization, triggering the release of pro-apoptotic factors. The chromatin structure and organization have strongly attracted because of their impacts in cellular phenotypes. Recent studies have been shown that changes in chromatin accessibility affect cell phenotypes for external stimuli. Since p53 plays an important role in drug sensitivity and 5-FU is an external stimulus for cancer cells, we hypothesized that p53 may effect on 5-FU sensitivity through different regulation of chromatin accessible regions between TP53-WT and TP53-KO cells. To determine the effect of p53 on chromatin accessibility modification associated with 5-FU sensitivity, ATAC-seq and RNA-seq were performed under 5-FU treatment on TP53-WT as drug sensitive and TP53-KO as drug resistant HCT116 cells. In this study, we found that 5-FU induces chromatin accessibility in both TP53-WT and TP53-KO cells. Moreover, our results show that 5-FU induced chromatin accessibility increases expression of apoptotic genes in TP53-WT HCT116 cells through p53 non-transcriptional activity in nucleus.
|
|
|
Overall design |
Examination of 2 different ATAC-seq in TP53-WT and TP53-KO HCT116 cells
|
|
|
Contributor(s) |
Yang CM, Jung W, Ju J, Kim Y |
Citation(s) |
33613715 |
|
https://doi.org/10.3892/ol.2021.12487
|
|
Submission date |
Sep 15, 2020 |
Last update date |
Apr 07, 2021 |
Contact name |
Hyoung-Pyo Kim |
E-mail(s) |
kimhp@yuhs.ac
|
Organization name |
Yonsei University College of Medicine
|
Department |
Department of Tropical Medicine
|
Street address |
Yonsei-ro 50-1
|
City |
Seoul |
ZIP/Postal code |
03722 |
Country |
South Korea |
|
|
Platforms (1) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (2) |
|
This SubSeries is part of SuperSeries: |
GSE158021 |
Different p53 status controls resistance to 5-fluorouracil via distinct chromatin accessibility dynamics in human colorectal cancer cell line |
|
Relations |
BioProject |
PRJNA663473 |
SRA |
SRP282434 |